Receivables

9 Months Ended

Sep. 30, 2025

The following table displays a roll forward of the allowance for doubtful trade receivables.


(in Millions)
Balance, December 31, 2023	$	29.1
Additions - charged to expense	12.2
Transfer from (to) allowance for credit losses (see below)	(3.6)
Net recoveries, write-offs and other	1.7
Balance, December 31, 2024	$	39.4
Additions - charged to expense	6.6
Transfer from (to) allowance for credit losses (see below)	0.1
Net recoveries, write-offs and other	(0.3)
India held for sale (See Note 1.)	(3.6)
Balance, September 30, 2025	$	42.2

We have non-current receivables that represent long-term customer receivable balances related to past due accounts which are not expected to be collected within the current year. The net long-term customer receivables were $79.4 million as of September 30, 2025. These long-term customer receivable balances and the corresponding allowance are included in "Other assets including long-term receivables, net" on the consolidated balance sheets.

A portion of these long-term receivables have payment contracts. We have no reason to believe payments will not be made based upon the credit quality of these customers. Additionally, we also hold significant collateral against these customers including rights to property or other assets as a form of credit guarantee. If the customer does not pay or gives indication that they will not pay, these guarantees allow us to start legal action to block the sale of the customer’s harvest.

The following table displays a roll forward of the allowance for credit losses related to long-term customer receivables:


(in Millions)
Balance, December 31, 2023	$	27.1
Additions - charged (credited) to expense	(1.8)
Transfer from (to) allowance for doubtful accounts (see above)	3.6
Foreign currency adjustments	(3.4)
Net recoveries, write-offs and other	(4.2)
Balance, December 31, 2024	$	21.3
Additions - charged (credited) to expense	0.8
Transfer from (to) allowance for doubtful accounts (see above)	(0.1)
Foreign currency adjustments	1.2
Net recoveries, write-offs and other	—
Balance, September 30, 2025	$	23.2

Receivables Securitization Facility:

FMC participates in certain trade receivables securitization programs, primarily impacting our Brazilian operations. On a revolving basis, FMC may sell certain trade receivables into the facilities in exchange for cash. A portion of the total receivables sold are deferred as an asset within "Other assets including long-term receivables, net" as presented on our consolidated balance sheets representing FMC’s beneficial interest in the securitization funds.

In all instances, the transferred financial assets are sold on a non-recourse basis and have met the true sale criteria under ASC Topic 860. FMC has surrendered control of the receivables and as a result they are no longer recognized on the consolidated balance sheets. FMC may be engaged to serve as a special servicer for any delinquent receivables. In that capacity, we are entitled to market rate compensation for those services.

Cash receipts from the sale of trade receivables under the securitization arrangements, received at the time of sale, are classified as cash flows from operating activities.

There were $134.0 million in receivables sold under the securitization programs during the nine months ended September 30, 2025. A $10.4 million charge associated with the transfer of these financial assets is included as a component within "Selling, general and administrative expenses" during the nine months ended September 30, 2025. There were $128.4 million in receivables sold under the securitization program during the nine months ended September 30, 2024. A $11.9 million charge associated with the transfer of these financial assets is included as a component within "Selling, general and administrative expenses" during the nine months ended September 30, 2024.

As part of funding our interest for all outstanding arrangements under the securitization programs, a portion of the receivables sold are retained by the investment fund and returned to FMC, including interest, at the maturity of the program. The fair value of the asset is approximately $40.1 million and is recorded within "Other assets including long-term receivables, net" on the consolidated balance sheets.

Other Receivable Factoring:

In addition to the above, we may sell trade receivables on a non-recourse basis to third-party financial institutions. These sales are normally driven by specific market conditions, including, but not limited to, foreign exchange environments, customer credit management, as well as other factors where the receivables originate.

We account for these transactions as true sales and as a result they are no longer recognized on the consolidated balance sheets because the agreements transfer effective control and risk related to the receivables to the buyers. The net cash proceeds received are presented within cash provided by operating activities within our consolidated statements of cash flows. The cost of factoring these accounts receivables is recorded within "Selling, general and administrative expenses" on the consolidated statements of income (loss) and has been inconsequential during each reporting period. Non-recourse factoring during the nine months ended September 30, 2025 and 2024 was $206.2 million and $71.3 million, respectively.